IJMS | Free Full-Text | Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta
Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trials | Multidisciplinary Respiratory Medicine | Full Text
Swansea University to trial Carragelose nasal spray to prevent COVID-1
Agovirax – Virus Prevention and Therapy - Agovirax
Iota-Carrageenan - an overview | ScienceDirect Topics
The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review | Semantic Scholar
A study protocol for a double-blind randomised placebo-controlled trial evaluating the efficacy of carrageenan nasal and throat spray for COVID-19 prophylaxis—ICE-COVID | Trials | Full Text
Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro | PLOS ONE
Lemsip First Action Nasal Spray 20Ml
The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review
IJMS | Free Full-Text | Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta
Carrageenan | C23H23FN4O7Zn - PubChem
IJMS | Free Full-Text | Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta